NL-OMON20530
Completed
Not Applicable
Early treatment of central serous retinopathy by photodynamic therapy. A randomized controlled trial.
Het Oogziekenhuis RotterdamSchiedamse Vest 180 3011 BH Rotterdam Nederland 0 sites60 target enrollmentTBD
ConditionsCentral serous retinopathy.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Central serous retinopathy.
- Sponsor
- Het Oogziekenhuis RotterdamSchiedamse Vest 180 3011 BH Rotterdam Nederland
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Missotten TOAR, Hoddenbach JG, Eenhorst CAE, van den Born LI, Martinez Ciriano JP, Wubbels RJ. A randomized clinical trial comparing prompt photodynamic therapy (PDT) with three months observation in patients with acute central serous chorioretinopathy (CSC) with central macular leakage, Eur J Ophthalmol, [Epub]. PMID: 32264706
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age \> 18 years;
- •2\. Informed consent;
Exclusion Criteria
- •1\. History of CSR in either eye;
- •2\. Allergy to fluorescein dyes;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Early treatment of central serous retinopathy by photodynamic therapy. A randomized controlled trial.central serous retinopathy10047060NL-OMON45189Oogziekenhuis Rotterdam60
Completed
Phase 1
Topical Interferon Gamma-1b for Central Serous ChorioretinopathyRetinal DiseaseMacular DiseaseNCT01468337National Eye Institute (NEI)5
Completed
Not Applicable
Persona of Central Serous ChorioretinopathyPersonality TypeNCT02819622Rafic Hariri University Hospital83
Completed
Not Applicable
ong term follow-up of central serous retinopathy. An observational case series.central serous retinopathy10047060NL-OMON31151Oogziekenhuis Rotterdam100
Completed
Not Applicable
Central Serous Chorioretinopathy: Etiology, Course and PrognosisCentral Serous ChorioretinopathyNCT01378130Medical University of Vienna50